The impact of laboratory features and comorbidities on the prognosis of patients with COVID-19

Basit Öğe Kaydı
dc.contributor.authorSarıcı, Ahmet
dc.contributor.authorBerber, Nurcan
dc.contributor.authorÇağasar, Özlem
dc.contributor.authorBiçim, Soykan
dc.contributor.authorCagin, Yasir Furkan
dc.contributor.authorUlutaş, Özkan
dc.contributor.authorGözükara Bağ, Harika
dc.contributor.authorBerber, İlhami
dc.date.accessioned2022-02-07T08:10:22Z
dc.date.available2022-02-07T08:10:22Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: Objective: Demographic and laboratory values predicting clinical severity in coronavirus disease 2019 (COVID-19) patients havebeen a matter of curiosity since the beginning of the disease. We aimed to show the relationship between the severity of COVID-19disease and comorbidities, clinical and laboratory features of the patients.Material and Method: The data of COVID-19 patients diagnosed with polymerase chain reaction (PCR), were analyzed retrospectively.The patients were divided into 3 groups according to their clinical severity as mild, moderate and severe. Comorbidities and theCharlson comorbidity index (CCI) at the time of diagnosis were calculated for each patient from the patients’ records. Demographicdata, laboratory values, comorbidity and CCI scores were compared between the patient groups. The effect of CCI on survival andlength of hospital stay was examined.Results: One hundred and four patients were included in the trial. The most common comorbid disease in the patients included in thetrial was hypertension. The moderate-severe stage patients were statistically significantly older (p<0.001). The CCI was found to bestatistically significantly different between mild, moderate and severe groups (p<0.001). When CCI increases by one unit, the risk ofdeath increases by 1.193 times (p=0.017). The neutrophil-to-lymphocyte ratio (NLR) was statistically significantly different betweenthe mild, moderate and severe patient groups. It was observed that as the severity of the disease increased, the NLR increased. Olderage, WBC, neutrophil count, NLR, BUN, creatinine, AST, potassium level, C-reactive protein (CRP), procalcitonin, aPTT, fibrinogen,d-dimer, and ferritin levels were found to be higher in the clinically severe patient group. Lymphocyte and eosinophil counts, totalprotein, albumin and sodium levels were found to be lower in the clinically severe patient group.Conclusion: This trial showed that calculating the CCI score in COVID-19 patients can be useful in predicting the severity of thedisease. Examination of CCI, age, WBC, neutrophil, lymphocyte, eosinophil counts, BUN, creatinine, AST, total protein, albumin,sodium, potassium level, CRP, procalcitonin, aPTT, fibrinogen, d-dimer and ferritin levels at the time of diagnosis can be suggested.en_US
dc.identifier.citationSARICI A,BERBER N,ÇAĞASAR Ö,BİÇİM S,CAGİN Y. F,ULUTAŞ Ö,BAĞ H. G,YAKUPOĞULLARI Y,BERBER İ (2021). The impact of laboratory features and comorbidities on the prognosis of patients with COVID-19. Journal of health sciences and medicine (Online), 4(2), 142 - 146. Doi: 10.32322/jhsm.839303en_US
dc.identifier.doi10.32322/jhsm.839303en_US
dc.identifier.endpage146en_US
dc.identifier.issn2636-8579
dc.identifier.issue2en_US
dc.identifier.startpage142en_US
dc.identifier.trdizinid433670en_US
dc.identifier.urihttps://doi.org/10.32322/jhsm.839303
dc.identifier.urihttps://hdl.handle.net/11616/46673
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/433670
dc.identifier.volume4en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofJournal of health sciences and medicine (Online)en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleThe impact of laboratory features and comorbidities on the prognosis of patients with COVID-19en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
1b752d46-75f6-4f18-a1cd-d0169a3daff8.pdf
Boyut:
144.39 KB
Biçim:
Adobe Portable Document Format
Açıklama:
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu